Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3038 |
|
| Actual shortage: | 229 (8%) | |
| Anticipated shortage: | 14 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2786 (92%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (12%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-ESOMEPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2022-09-01 | 2022-10-31 | 168364 |
| APO-FLUVOXAMINE | 50MG | TABLET | Resolved | 2022-09-01 | 2022-10-07 | 168367 |
| APO-LETROZOLE | 2.5MG | TABLET | Resolved | 2022-09-01 | 2022-09-16 | 168415 |
| APO-MOMETASONE | 50MCG | SPRAY, METERED DOSE | Resolved | 2022-09-01 | 2022-09-15 | 168418 |
| APO-NAPROXEN | 375MG | TABLET | Resolved | 2022-09-01 | 2022-11-20 | 168421 |
| APO-PERINDOPRIL-INDAPAMIDE | 1.25MG 4MG | TABLET | Resolved | 2022-09-01 | 2022-09-23 | 168424 |
| APO-SUCRALFATE - TAB 1G | 1G | TABLET | Resolved | 2022-09-09 | 2023-09-22 | 169045 |
| APO-LANSOPRAZOLE | 15MG | CAPSULE (DELAYED RELEASE) | Resolved | 2022-09-09 | 2022-10-14 | 169048 |
| APO-CINACALCET | 90MG | TABLET | Resolved | 2022-09-09 | 2022-10-07 | 169051 |
| APO-MONTELUKAST | 5MG | TABLET (CHEWABLE) | Resolved | 2022-09-09 | 2022-12-05 | 169054 |
| APO-RIZATRIPTAN | 5MG | TABLET | Resolved | 2022-09-09 | 2022-10-14 | 169057 |
| APO-PANTOPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2022-09-09 | 2022-09-30 | 169060 |
| APO-FLUOXETINE | 20MG | CAPSULE | Resolved | 2022-09-16 | 2022-09-30 | 169510 |
| APO-NAPROXEN | 500MG | TABLET | Resolved | 2022-09-16 | 2022-11-26 | 169513 |
| APO-SIMVASTATIN | 40MG | TABLET | Resolved | 2022-09-16 | 2022-11-25 | 169516 |
| APO-ALENDRONATE/VITAMIN D3 | 2800UNIT 70MG | TABLET | Resolved | 2022-09-16 | 2022-10-07 | 169519 |
| APO-ACETAMINOPHEN | 325MG | TABLET | Resolved | 2022-09-23 | 2022-10-21 | 170106 |
| APO-BUSPIRONE | 10MG | TABLET | Resolved | 2022-09-23 | 2022-10-21 | 170109 |
| APO-PRAVASTATIN | 20MG | TABLET | Resolved | 2022-09-23 | 2022-11-04 | 170112 |
| APO-VALPROIC ACID | 250MG | CAPSULE | Resolved | 2022-09-23 | 2023-05-12 | 170115 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-ACEBUTOLOL | 400MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4965 |
| APO-OLANZAPINE | 5.0MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4968 |
| APO-SOTALOL | 160MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4971 |
| APO-TERAZOSIN | 2MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4974 |
| APO-DOCUSATE SODIUM | 100MG | CAPSULE | Discontinued | 2018-02-23 | 2019-03-29 | 40733 |
| DOCUSATE SODIUM CAPSULES | 100MG | CAPSULE | Discontinued | 2018-02-23 | 2018-09-15 | 40738 |
| APO-FENTANYL MATRIX | 100MCG | PATCH | Discontinued | 2018-02-23 | 2018-12-28 | 40741 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-02-23 | 40757 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40760 |
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40766 |
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40769 |
| APO-METFORMIN | 850MG | TABLET | Discontinued | 2018-02-23 | 2019-06-12 | 40778 |
| APO-METFORMIN | 500MG | TABLET | To be discontinued | 2018-02-23 | 2018-12-28 | 40781 |
| APO-METFORMIN | 500MG | TABLET | To be discontinued | 2018-02-23 | 2018-12-28 | 40784 |
| APO-METFORMIN | 500MG | TABLET | Discontinued | 2018-02-23 | 2018-11-26 | 40790 |
| APO-METFORMIN | 850MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40796 |
| APO-RABEPRAZOLE | 10MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-02-23 | 2019-09-12 | 40805 |
| APO-TELMISARTAN | 40MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40811 |
| APO-TELMISARTAN | 40MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40814 |